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Abstract
& The Open Access Series of Imaging Studies is a series of mag-
netic resonance imaging data sets that is publicly available for
study and analysis. The initial data set consists of a cross-sectional
collection of 416 subjects aged 18 to 96 years. One hundred of
the included subjects older than 60 years have been clinically
diagnosed with very mild to moderate Alzheimer’s disease. The
subjects are all right-handed and include both men and women.
For each subject, three or four individual T1-weighted magnetic
resonance imaging scans obtained in single imaging sessions are
included. Multiple within-session acquisitions provide extremely
high contrast-to-noise ratio, making the data amenable to a wide
range of analytic approaches including automated computational
analysis. Additionally, a reliability data set is included containing
20 subjects without dementia imaged on a subsequent visit
within 90 days of their initial session. Automated calculation of
whole-brain volume and estimated total intracranial volume are
presented to demonstrate use of the data for measuring differ-
ences associated with normal aging and Alzheimer’s disease. &
INTRODUCTION
The Open Access Series of Imaging Studies (OASIS) is
a project aimed at making magnetic resonance imaging
(MRI) data sets of the brain freely available to the
scientific community. By compiling and freely distribut-
ing MRI data sets, we hope to facilitate future discoveries
in basic and clinical neuroscience. Specifically, the OASIS
project is intended to play a number of roles. First,
OASIS images and related measures serve as data sets for
continued scientific exploration. Beginning with the ini-
tial set of images obtained from more than 400 individ-
uals with and without dementia across the adult life
span, OASIS data sets are selected to encourage inves-
tigation of high interest topics and provide data that
would be difficult for individual laboratories to acquire.
Second, OASIS data are targets for researchers creating
and furthering analytic techniques. Because the images
are acquired from subjects over a range of ages and
health conditions, OASIS data can be used to test the
robustness and validity of techniques across the full
range of the human brain’s varied landscapes. Third,
OASIS data can be used as benchmark targets for com-
paring similar analytic techniques. Standard images pro-
vide a common point of reference for demonstrating and
contrasting methods. By providing carefully screened
data in an open-access fashion, the OASIS project can
provide such exemplar images to the neuroimaging com-
munity. Finally, OASIS data can be used for educational
purposes as examples or as working data sets for courses
and workshops.
A number of data-sharing procedures have been
adopted by the OASIS project to ensure the integrity
and usability of the provided data.
1. Quality control. All images are carefully screened
for acquisition and processing errors. Images with severe
artifacts are excluded from the distribution. Images with
visible artifacts typical of MR acquisitions are included.
This variability in quality is intended to provide tool
builders with realistic target images.
2. Documentation. Detailed acquisition protocols and
parameters, demographics, and supporting measures
(e.g., Mini-Mental State Examination [MMSE] scores) are
provided for all included images.
3. Preparation. In addition to the raw acquisition data,
images representing common postprocessing procedures
(e.g., atlas registration, bias field correction) are distrib-
uted as a convenience and for comparison with similar
postprocessing methods.
4. Anonymization. In compliance with privacy regula-
tions, distributed data are assigned random identification
numbers (IDs), and all identifying information are re-
moved from the image files. All links between original and
random IDs are permanently destroyed before release.
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5. Access. The data are available on DVD and acces-
sible for viewing and downloading via a dedicated Web
site. Third parties are encouraged to redistribute the
data in ways that add to its general availability.
6. Ongoing support. The OASIS Web site will serve as
a forum for announcements and discussions regarding
the distributions and as a clearinghouse for third party
derived data sets.
7. Unrestricted usage. OASIS data may be freely
used with no restrictions. Attributions to the OASIS pro-
ject will lend to the credence of OASIS as a reference
resource. Anyone wishing to distribute derived data will
be encouraged to include the original images. The
OASIS Data Use Agreement is available at www.oasis-
brains.org.
In the remainder of this article, we describe the first
OASIS data set release. This release includes cross-
sectional data from 416 individuals across the adult life
span age 18 to 96 years, including 100 individuals with
very mild to moderate Alzheimer’s disease (AD) as
diagnosed clinically and characterized using the Clini-
cal Dementia Rating (CDR) scale (Morris et al., 2001;
Morris, 1993). Cross-sectional data have proven useful
in studying normal and diseased aging for both global
(whole-brain) and local structure. In normal aging,
whole-brain volume decline begins in early adulthood
and accelerates in advanced aging (DeCarli et al., 2005;
Fotenos, Snyder, Girton, Morris, & Buckner, 2005;
Sowell, Thompson, Leonard, et al., 2004; Durston,
2003; Blatter et al., 1995). Preferential volume loss of
gray matter (Raz, Williamson, Gunning-Dixon, Head, &
Acker, 2000) and regionally specific thinning of the cor-
tex are also noted (Salat et al., 2004). Level of educa-
tion, sex, socioeconomic status, and cardiovascular
health have been identified as contributing factors
in volume decline in advanced aging, suggesting that
subclinical health conditions contribute to age-related
changes in brain structure (Fotenos, Mintun, Snyder,
Morris, & Buckner, in press; Raz, Rodrigue, & Acker,
2003; Koga et al., 2002; Coffey, Saxton, Ratcliff, Bryan,
& Lucke, 1999; Coffey et al., 1998). Individuals with
clinically diagnosed AD show substantially reduced over-
all brain volumes relative to age-matched peers as
well as regional volume loss that has been well docu-
mented in the hippocampal formation, among other
regions (e.g., Jack et al., 1997; Raz et al., 1997; Killiany
et al., 1993; Jack, Petersen, O’Brien, & Tangalos, 1992;
Scheltens et al., 1992). Cross-sectional MRI data have
also been used to facilitate and validate analytic tools
and algorithms, including atlas-based head size normal-
ization (Buckner et al., 2004), automated whole-brain
segmentation (Fischl et al., 2002), automated labeling
of cerebral cortex into regions of interest (Desikan
et al., 2006), and large-deformation maps of brain struc-
ture shape (Csernansky, Wang, Joshi, Ratnanather, &
Miller, 2004).
METHODS
Subjects
Subjects aged 18 to 96 years were selected from a larger
database of individuals who had participated in MRI
studies at Washington University, based on the availabil-
ity of at least three acquired T1-weighted images, right-
hand dominance, and a recent clinical evaluation for
older adults. Young and middle-aged subjects were re-
cruited from the Washington University community.
Older subjects with and without dementia were ob-
tained from the longitudinal pool of the Washington
University Alzheimer Disease Research Center (ADRC).
The ADRC’s normal and cognitively impaired subjects
were recruited primarily through media appeals and
word of mouth, with 80% of subjects initiating contact
with the center and the remainder being referred by
physicians (Berg et al., 1982, 1998). All subjects partici-
pated in accordance with guidelines of the Washington
University Human Studies Committee. Approval for pub-
lic sharing of the data was also specifically obtained.
All subjects were screened for inclusion in this release.
Young and middle-aged adults were questioned before
image acquisition by a trained technician about their
medical histories and use of psychoactive drugs. Older
adults, aged 60 and older, underwent the ADRC’s full
clinical assessment as described below. Subjects with a
primary cause of dementia other than AD (e.g., vascular
dementia, primary progressive aphasia), active neuro-
logical or psychiatric illness (e.g., major depression), se-
rious head injury, history of clinically meaningful stroke,
and use of psychoactive drugs were excluded, as were
subjects with gross anatomical abnormalities evident in
their MRI images (e.g., large lesions, tumors). However,
subjects with age-typical brain changes (e.g., mild atro-
phy, leukoaraiosis) were accepted. MRI acquisitions typi-
cally were obtained within a year of a subject’s clinical
assessment (mean = 105 days, range = 0–314 days).
Three subjects with AD were scanned after a some-
what longer duration (635, 449, and 443 days). The
final data set includes 416 subjects. Twenty subjects in
their twenties were imaged on a second occasion within
90 days of their initial session to provide a means for
assessing reliability of data acquisition and analysis.
Portions of the clinical, demographic, and image data
obtained from subjects in this release have been used in
previous studies (Buckner et al., 2004, 2005, in press;
Burns et al., 2005; Fotenos et al., 2005, in press; Head,
Snyder, Girton, Morris, & Buckner, 2005; Salat et al.,
2004) and made publicly available, using different anon-
ymous identifiers, via the fMRI Data Center under acces-
sion number 2-2004-1168x.
Clinical Assessment
Dementia status was established and staged using the
CDR scale (Morris et al., 2001; Morris, 1993). The deter-
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mination of AD or control status is based solely on clinical
methods, without reference to psychometric perfor-
mance, and any potential alternative causes of dementia
(known neurological, medical, or psychiatric disorders)
must be absent. The diagnosis of AD is based on clinical
information (derived primarily from a collateral source)
that the subject has experienced gradual onset and pro-
gression of decline in memory and other cognitive and
functional domains. Specifically, the CDR is a dementia-
staging instrument that rates subjects for impairment
in each of the six domains: memory, orientation, judg-
ment and problem solving, function in community affairs,
home and hobbies, and personal care. Based on the
collateral source and subject interview, a global CDR
score is derived from individual ratings in each domain.
A global CDR of 0 indicates no dementia, and CDRs of
0.5, 1, 2, and 3 represent very mild, mild, moderate, and
severe dementia, respectively. These methods allow for
the clinical diagnosis of AD in individuals with a CDR of
0.5 or greater, based on standard criteria (McKhann et al.,
1984), that is confirmed by histopathological examination
in 93% of the individuals (Berg et al., 1998), even for those
in the earliest symptomatic stage (CDR 0.5) of AD who
elsewhere may be considered to represent ‘‘mild cogni-
tive impairment’’ (Storandt, Grant, Miller, & Morris, 2006).
Image Acquisition
For each subject, 3–4 individual T1-weighted magne-
tization prepared rapid gradient-echo (MP-RAGE) im-
ages (Mugler & Brookeman, 1990) were acquired on
a 1.5-T Vision scanner (Siemens, Erlangen, Germany)
in a single imaging session. Head movement was mini-
mized by cushioning and a thermoplastic face mask.
Headphones were provided for communication. A vi-
tamin E capsule was placed over the left forehead to
provide a reference marker of anatomical side. Posi-
tioning was low in the head coil (toward the feet) to
optimize imaging of the cerebral cortex. MP-RAGE pa-
rameters were empirically optimized for gray–white
contrast (Table 1). An example of typical images is illus-
trated in Figure 1.
Table 1. MRI Acquisition Details
Sequence MP-RAGE
TR (msec) 9.7
TE (msec) 4.0
Flip angle (8) 10
TI (msec) 20
TD (msec) 200
Orientation Sagittal
Thickness, gap (mm) 1.25, 0
Slice number 128
Resolution (pixels) 256  256 (1  1 mm)
Figure 1. Typical MRI data set. (A) Individual scan before defacing. (B) Same scan after defacing. Note that the defacing process leaves the
cranial vault intact while identifying facial features are removed. (C) Averaged motion-corrected image. Note improved signal-to-noise ratio.
(D) Atlas-registered gain-field-corrected image. (E) Tissue classification image.
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Postprocessing
For each subject, the individual scan files were converted
from Siemens proprietary IMA format into 16-bit Analyze
7.5 format using a custom conversion program. Sensitive
header fields (patient ID, experiment date) were left
blank. Identifying facial features were then removed from
the images using software provided by the fMRI Data
Center (www.fmridc.org). This method first masks out all
nonbrain voxels in the image, dilates and smoothes the
mask in an iterative fashion, and finally applies the
enlarged mask to the original image to safely remove
voxels outside the cranial vault. In 12 cases where this
method either left too much of the face present or
invasively cut into the cranial vault, de-identification was
done using software provided by the Morphometry Bio-
medical Informatics Research Network (www.nbirn.net).
This method registers the image to an atlas in which facial
features and brain tissue have been hand-labeled. All
voxels in the image that have a zero probability of being
brain and a nonzero probability of being face are assigned
an intensity value of zero. The de-identified images are the
images included in the present distribution and were used
in all subsequent processing and analyses described here.
The images were then corrected for interscan head
movement and spatially warped into the atlas space of
Talairach and Tournoux (1988) using a rigid transforma-
tion that differs in process from the original piecewise
scaling. The resulting transformation nonetheless places
the brains in the same coordinate system and bounding
box as the original atlas. The template atlas used here
consisted of a combined young-and-old target previously
generated from a representative sample of young subjects
(n = 12) and old subjects without dementia (n = 12).
The use of a combined template has been shown to mini-
mize the potential bias of an atlas normalization proce-
dure to overexpand atrophied brains (Buckner et al.,
2004). For registration, a 12-parameter affine transforma-
tion was computed to minimize the variance between the
first MP-RAGE image and the atlas target (Snyder, 1996).
The remaining MP-RAGE images were registered to the
first (in-plane stretch allowed) and resampled via trans-
form composition into a 1-mm isotropic image in atlas
space. The result was a single, high-contrast, averaged
MP-RAGE image in atlas space. Subsequent steps included
skull removal by application of a loose-fitting atlas mask
and correction for intensity inhomogeneity due to non-
uniformity in the magnetic field. Intensity variation was
corrected across contiguous regions, based on a quadratic
inhomogeneity model fitted to data from a phantom
(Styner, Brechbuhler, Szekely, & Gerig, 2000).
Estimated Total Intracranial Volume
and Normalized Whole-brain Volume
The procedures used for measuring intracranial and
whole-brain volumes have been described in detail
previously (Fotenos et al., 2005; Buckner et al., 2004).
In brief, estimated total intracranial volume (eTIV) was
computed by scaling the manually measured intracranial
volume of the atlas by the determinant of the affine
transform connecting each individual to the atlas. This
method has been shown to be proportional to manually
measured total intracranial volume (TIV, r = 0.94) and
minimally biased by atrophy (Buckner et al., 2004).
Normalized whole-brain volume (nWBV) was comput-
ed using the FAST program in the FSL software suite
(www.fmrib.ox.ac.uk/fsl) (Zhang, Brady, & Smith, 2001).
The image was first segmented to classify brain tissue as
cerebral spinal fluid, gray matter, or white matter. The
segmentation procedure iteratively assigned voxels to
tissue classes based on maximum likelihood estimates of
a hidden Markov random field model. The model used
spatial proximity to constrain the probability with which
voxels of a given intensity are assigned to each tissue
class. Finally, nWBV was computed as the proportion
of all voxels within the brain mask classified as gray or
white matter. The unit of normalized volume is percent,
which represents the percentage of the total segmented
voxels within the eTIV (Fotenos et al., 2005).
Quality Control
All images in the set were carefully screened for artifacts,
acquisition problems, and processing errors. During the
screening process, each image was viewed on a per-slice
basis along each principal axis. Each image was assigned
a value from 1 to 3, with 1 indicating a high-quality im-
age, 2 indicating a scan with minor flaws, and 3 indicat-
ing severe flaws. Typical flaws included electronic noise
resulting in bright lines through multiple slices, motion
artifacts appearing as hazy bands across the image, poor
head positioning resulting in wraparound artifacts, dis-
tortions from dental work, and limited image contrast
(Figure 2). Images with a rating of 3 were excluded from
the data set. A number of borderline images remain in
the distribution, providing tool builders and testers with
a realistic range of acquisition quality. In cases where
individual scans were deemed unusable, the single scan
was removed from the set but the remainder of the
subject’s scans was included. Overall, 10 individual scans
and 15 complete sessions were excluded from the final
release due to poor image quality.
RESULTS
Overview of the Data Set
The current data set consists of subjects across the adult
life span (Table 2). It includes 218 subjects aged 18 to
59 years and 198 subjects aged 60 to 96 years. The over-
all age distribution is presented in Figure 3. Each group
includes an approximately equal number of male and
female subjects. Of the older subjects, 98 had a CDR
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score of 0, indicating no dementia, and 100 had a CDR
score greater than zero (70 CDR = 0.5, 28 CDR = 1, 2
CDR = 2), indicating a diagnosis of very mild to mod-
erate AD. Additional demographics and clinical charac-
teristics of the older subjects are shown in Table 3.
Anatomical Characteristics
As a means of determining whether defacing techniques
impact morphometric analysis, eTIV and nWBV were
calculated before and after defacing for each subject.
The slope of the best fit line was 1.00 (r = 1.00) for eTIV
and was 1.00 (r = 1.00) for nWBV. The mean absolute
percent differences before and after defacing were
0.024% for eTIV and 0.059% for nWBV. The defacing
process, therefore, has little impact on morphometric
measures of interest.
Having established that defacing has minimal impact,
eTIV and nWBV are plotted across the adult life span in
Figure 4 for the data included as part of the OASIS dis-
tribution. Analyses are selective and used to illustrate prop-
erties of the data. More detailed normative estimates of
Figure 2. Example images
illustrate the quality control
rating procedures. (A) A scan
that received a rating of 1,
indicating a high-quality image
with minimal artifacts and
high contrast. (B) A scan that
received a rating of 3 because
significant motion artifacts.
Such artifacts are particularly
apparent when scrolling
through multiple image
slices. (C) A scan that
received a rating of 2 because
of significant in-plane
wraparound. Because the
nose does not actually overlap
into brain tissue, this scan
was retained in the data set.
Such borderline images were
relatively rare. (D) A scan that
received a rating of 3 because
of severe in-plane wraparound
that cuts into the brain.
Table 2. Age and Diagnosis Characteristics of the Data Set
Without Dementia With Dementia
Age Group Total n n Mean Male Female n Mean Male Female CDR 0.5/1/2
<20 19 19 18.53 10 9 0 0 0 0/0/0
20s 119 119 22.82 51 68 0 0 0 0/0/0
30s 16 16 33.38 11 5 0 0 0 0/0/0
40s 31 31 45.58 10 21 0 0 0 0/0/0
50s 33 33 54.36 11 22 0 0 0 0/0/0
60s 40 25 64.88 7 18 15 66.13 6 9 12/3/0
70s 83 35 73.37 10 25 48 74.42 20 28 32/15/1
80s 62 30 84.07 8 22 32 82.88 13 19 22/9/1
90 13 8 91.00 1 7 5 92.00 2 3 4/1/0
Total 416 316 119 197 100 41 59
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eTIV and nWBV can be found in the study of Fotenos
et al. (2005) and Buckner et al. (2004). In the present
sample, eTIV showed a trend for a small age effect [R2 =
0.0022, F(1,158) = 0.35, p = .06 in men, and R2 = 0.12,
F(1,254) = 2.98, p = .09 in women] and a strong sex effect
in each of the young, middle-aged, old without dementia,
and old with dementia groups [t(215) = 10.81, t(95) =
6.42, t(97) = 5.41, respectively; all p < .001]. Consistent
with our prior work (Buckner et al., 2005), direct eTIV
comparison of age-matched groups with and without de-
Figure 3. Subjects by age, sex, and dementia status. Because of
the recruiting requirements of studies included in the database from
which the data set was culled, a disproportionately large number
of younger subjects were available. Nonetheless, at least 15 subjects
are included in each decade, allowing for continuous sampling of
the adult life span.
Table 3. Sample Characteristics of Older Subjects
CDR = 0 CDR = 0.5 CDR = 1 CDR = 2
Number 98 70 28 2
Sex (female/male) 72/26 39/31 19/9 1/1
Age (years) 75.9 ± 9.0 (60–94) 76.4 ± 7.0 (63–92) 77.2 ± 7.5 (62–96) 82 ± 5.7 (78–86)
Education (years) 14.5 ± 2.9 (8–23) 13.8 ± 3.2 (6–20) 12.9 ± 3.2 (7–20) 11 ± 4.2 (8–14)
MMSE score 29.0 ± 1.2 (25–30) 25.6 ± 3.5 (14–30) 21.7 ± 3.8 (15–29) 15.0 ± 0.0 (15)
Prescriptions (n) 2.8 ± 2.1 (0–8) 2.5 ± 2.0 (0–8) 2.2 ± 2.0 (0–6) 1.5 ± 0.7 (1–2)
Systolic BP (mmHg) 134.2 ± 19.2 (100–192) 142.6 ± 20.2 (104–188) 146.0 ± 25.6 (90–192) 148.0 ± 11.3 (140–156)
Diastolic BP (mmHg) 71.9 ± 10.3 (40–96) 72.7 ± 9.4 (59–90) 74.5 ± 10.6 (60–96) 88.0 ± 19.8 (74–102)
Reported HBP (%) 42.7 43.2 46.4 50.0
Diabetes (%) 9.1 11.6 17.2 0.0
The sample consisted of 198 individuals (98 without dementia and 100 with AD). Values given are mean ± SD. Values in parentheses represent the
range. Full clinical data were not available for 23 subjects. Compared with the adults without dementia, the older adults with dementia had lower
scores on the MMSE [t(194) = 10.66, p < .001] and slightly fewer years of education [t(194) = 2.60, p < .05].
MMSE scores range from 30 (best) to 0 (worst).
HBP = high blood pressure.
Figure 4. Plots of automated anatomical measures by age. Each
point represents a unique subject from a single scanning session.
(Top) eTIV: The best-fit line is drawn for individuals without
dementia only. (Bottom) nWBV: The best-fit polynomial regression
is drawn for individuals without dementia only.
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mentia failed to reach significance for either the men
[t(76) = 0.08, p = .94] or women [t(153) = 1.18, p = .24].
Consistent with the literature, nWBV showed a signif-
icant decrease in individuals without dementia across
the adult life span (18–95 years) [R2 = 0.75, F(2,313) =
485.7, p < .001]. Adding a quadratic term improved the
fit of the model [R2 = 0.78, F(2,313) = 557.1, p < .001).
The decrease in nWBV with age was significant even in
the 18- to 30-year-old group [R2 = 0.048, F(2,138) = 3.9,
p < .05]. Taken together, these results show brain vol-
ume loss begins early in life and accelerates in advanced
aging. Individuals with AD exhibited marked nWBV
reduction disproportionate to age. Analysis of variance
with age, sex, and dementia status as covariates was sig-
nificant [R2 = 0.44, F(194,3) = 50.4, p < .001], with main
effects for age and dementia status ( p < .001) and a
trend for an effect of sex ( p = .06).
Reliability Scans
To provide a benchmark for determining the reliability
of analytic procedures, 20 subjects were scanned on two
separate occasions with a mean delay of 20.55 days
(range = 1–89 days). These subjects did not have de-
mentia and ranged in age from 19 to 29 years. Because
of the short latency between scan sessions, differences
in the images and measures derived from them are un-
likely to be attributable to anatomical change and in-
stead can be attributed to sources of noise (e.g., head
positioning, day-to-day scanner variability) and instability
in analytic procedures. Figure 5 shows eTIV (top) and
nWBV (bottom) from the first session versus the second
session for each subject in the reliability data set. The
mean absolute percent difference was 0.54% for eTIV
and 0.44% for nWBV. The coefficients of variation (CVs,
the standard deviation of the difference between test and
retest volumes divided by the overall mean, expressed
in percent) were 0.47% for eTIV and 0.44% for nWBV.
Obtaining and Using the Data
OASIS data can be obtained at www.oasis-brains.org. Re-
quests for DVD distributions of the data can be sub-
mitted at the Web site. For convenience, we also provide
the data using the open-source Extensible Neuroimaging
Archive Toolkit (Marcus, Olsen, Ramaratnam, & Buckner,
2007). It provides tools to search, visualize, and down-
load the data. Before downloading and requesting
data, users are asked to abide by the OASIS Data Usage
Agreement.
OASIS data are distributed in GNU zip archive files,
which can be uncompressed using freely available soft-
ware. All images are distributed in Analyze 7.5 format,
which can be visualized and processed using a number
of commercial and open source applications, including
Neurolens, ImageJ, and MRIcro. For each imaging ses-
sion, the following image files are included in the
distribution: three to four individual scan images; an
image in which the individual scans have been aligned
and coregistered; an image that has been gain-field-
corrected and registered to the atlas of Talairach and
Tournoux (1988) (henceforth T88); a masked T88 image
in which the intensity of all nonbrain voxels has been set
to zero; and a segmented T88 image in which each voxel
has been labeled as gray matter, white matter, or
cerebral spinal fluid. Demographic, clinical, and derived
Figure 5. Plots of automated anatomical measures for reliability
scans. Each point represents the values of the anatomical measure
calculated from images obtained from the same subject without
dementia on two separate scan sessions separated by a short
interval (<90 days). The reliability of eTIV (top, r = 0.99) and
nWBV (bottom, r = 0.96) are high.
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imaging measures (Table 4) are available in XML and
spreadsheet formats. Additional details of the directory
structure, file naming scheme, and image characteristics
can be found at www.oasis-brains.org/pdf/oasis_cross-
sectional_facts.pdf.
DISCUSSION
The present data set includes T1-weighted MRI data
from 416 individuals aged 18 to 96 years, including 100
individuals clinically diagnosed with AD. Multiple acqui-
sitions are included for each subject, allowing extremely
high contrast properties after image averaging. These
data are amenable to a range of analysis procedures.
The data have been de-identified, carefully screened for
image quality, and postprocessed to generate common
anatomical measures. These data are available under a
liberal usage policy that allows free access to all inter-
ested parties.
To accommodate public release of the data, the orig-
inal images were processed to remove facial features.
The methods used to accomplish this have been shown
to reliably prevent the recognition of particular individ-
uals (Bischoff-Grethe et al., in press). Here, we have ad-
ditionally shown that these methods do not significantly
impact typical calculations of anatomical measures such
as intracranial volume and whole-brain volume.
The specific anatomical measures included here, eTIV
and nWBV, are illustrative of approaches commonly
used to analyze anatomical characteristics of the brain
in MRI images, particularly in relation to aging. Unsur-
prisingly, our findings are in agreement with those de-
scribed in previous studies using portions of these data
before defacing (Fotenos et al., 2005; Buckner et al.,
2004). In particular, eTIV was shown to differ little with
age and dementia status. Because the atlas-based meth-
ods used to generate eTIV are entirely automated, eTIV
is an attractive alternative to laborious manual TIV mea-
sures for correcting for head size in studies of aging and
dementia. nWBV, on the other hand, was shown to de-
cline across the adult life span with acceleration in ad-
vanced aging, consistent with findings from a broad
range of studies (see DeCarli et al., 2005; Fotenos et al.,
2005; Sowell, Thompson, & Toga, 2004; Durston, 2003;
Blatter et al., 1995, for reviews). Marked volume loss was
observed in AD.
This distribution also includes data from 20 individ-
uals who were scanned on two occasions separated by a
short interval. Because little real change in anatomical
structure is likely to have occurred between the two
acquisitions, these images are useful for estimating the
reliability of analytic methods. The measures of eTIV
and nWBV described here provide a reference point for
the amount of error seen with established approaches.
However, because these scans were all obtained from
young healthy individuals, reliability may be overesti-
mated relative to a sample of older subjects with de-
mentia who are more prone to movement and other
artifacts.
Although other publicly available neuroimaging data
sets are available, most notably those provided by the
Alzheimer’s Disease Neuroimaging Initiative (ADNI), the
present data set contributes complimentary features.
First, ADNI targets mild cognitive impairment and AD
and, by design, includes a limited number of older adults
without dementia and no individuals before middle age.
The present data set targets the full adult life span and,
therefore, allows exploration of aging in addition to
effects of AD. Second, ADNI is a multicenter study that
will be extremely valuable for developing methods that
can pool across sites. There will not, however, be a large
quantity of matched data sets from the same scanner/
sequence type. The present data includes more than
400 subjects with data collected on the identical plat-
form with identical sequences. Finally, in the present
data set, multiple acquisitions were acquired for each
subject within session to allow substantial signal aver-
aging. This is not typically done, and this choice was
made to optimize our data for exploration of automated
Table 4. Measures Included in the Data Set
Age Age at time of image
acquisition (years)
Sex Sex (male or female)
Education Years of education
Socioeconomic status Assessed by the Hollingshead Index
of Social Position and classified
into categories from 1 (highest
status) to 5 (lowest status)
(Hollingshead, 1957)
MMSE score Ranges from 0 (worst) to 30 (best)
(Folstein, Folstein, & McHugh,
1975)
CDR scale 0 = no dementia, 0.5 = very mild
AD, 1 = mild AD, 2 = moderate
AD (Morris, 1993)
Atlas scaling factor Computed scaling factor (unitless)
that transforms native-space brain
and skull to the atlas target (i.e.,
the determinant of the transform
matrix) (Buckner et al., 2004)
eTIV Estimated total intracranial volume
(cm3) (Buckner et al., 2004)
nWBV Expressed as the percent of all
voxels in the atlas-masked image
that are labeled as gray or white
matter by the automated tissue
segmentation process (Fotenos
et al., 2005)
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computational analyses, including measures of cortical
thickness and fine demarcation of subcortical regions.
The result is 416 scanning sessions, each with high-
contrast imaging data that are amenable to a wide range
of computational analyses.
A number of additional data sets are planned as part
of the OASIS project. These will include longitudinal
acquisitions of individuals with and without dementia,
acquisitions from subjects obtained on multiple different
scanners, functional MRI of cognition, and resting-state
functional MRI for noise analysis and analysis of sponta-
neous low-frequency signals. Following the principles
established with the initial release, these sets will be
carefully prepared, vetted, and described.
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